Editas Medicine (EDIT) SEC Filings & 10K Form

$5.60
+0.11 (+2.00%)
(As of 04/22/2024 ET)

Recent Editas Medicine SEC Filings

DateFilerForm TypeView
04/16/2024
3:30 PM
Editas Medicine (Filer)
Form DEFA14A
04/16/2024
3:25 PM
Editas Medicine (Filer)
Form DEF 14A
04/10/2024
8:37 AM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
03/05/2024
6:54 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:00 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:03 PM
Burkly Linda (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2024
7:06 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2024
4:13 PM
Editas Medicine (Filer)
Form S-3ASR
02/28/2024
3:39 PM
Editas Medicine (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2024
6:06 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:40 AM
Deep Track Capital, LP (Filed by)
Editas Medicine (Subject)
Form SC 13G/A
01/24/2024
1:27 PM
BlackRock Inc. (Filed by)
Editas Medicine (Subject)
Form SC 13G/A
01/10/2024
8:09 AM
Editas Medicine (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
12/13/2023
8:02 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/11/2023
3:23 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
3:30 PM
Eaton Bruce (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/22/2023
3:10 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/16/2023
3:30 PM
Eaton Bruce (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/03/2023
6:06 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/07/2023
3:59 PM
Eaton Bruce (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2023
3:30 PM
Eaton Bruce (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/02/2023
6:16 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/21/2023
3:30 PM
Editas Medicine (Issuer)
Mei Baisong (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/15/2023
3:30 PM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/15/2023
3:22 PM
Editas Medicine (Filer)
Form 424B5
06/14/2023
4:20 PM
Editas Medicine (Filer)
Form 424B5
06/09/2023
5:01 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/07/2023
3:30 PM
Eaton Bruce (Reporting)
Editas Medicine (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
3:30 PM
Editas Medicine (Issuer)
O'Neill Gilmore Neil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/18/2023
4:18 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/18/2023
4:20 PM
Editas Medicine (Issuer)
Lucera Erick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2023
5:41 PM
Editas Medicine (Subject)
ROBERTSON MICHELLE (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2023
3:16 PM
Editas Medicine (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/05/2023
6:16 AM
Editas Medicine (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:EDIT) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners